The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
A Comprehensive Understanding of Post-Translational Modification of Sox2 via Acetylation and O-GlcNAcylation in Colorectal Cancer
Open accessAbstract
Aberrant expression of the pluripotency-associated transcription factor Sox2 is associated with poor prognosis in colorectal cancer (CRC). We investigated the regulatory roles of major post-translational modifications in Sox2 using two CRC cell lines, SW480 and SW620, derived from the same patient but with low and high Sox2 expression, respectively. Acetylation of K75 in the Sox2 nuclear export signal was relatively increased in SW480 cells and promotes Sox2 nucleocytoplasmic shuttling and proteasomal degradation of Sox2. LC-MS-based proteomics analysis identified HDAC4 and p300 as binding partners involved in the acetylation-mediated control of Sox2 expression in the nucleus. Sox2 K75 acetylation is mediated by the acetyltransferase activity of CBP/p300 and ACSS3. In SW620 cells, HDAC4 deacetylates K75 and is regulated by miR29a. O-GlcNAcylation on S246, in addition to K75 acetylation, also regulates Sox2 stability. These findings provide insights into the regulation of Sox2 through multiple post-translational modifications and pathways in CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Sox2’s acetylation was further connected to cellular metabolism as acetyl-CoA synthetase 2 (ACSS2, a key acetyl-CoA producing enzyme) expression was inversely correlated with Sox2 expression, so much so that ACSS2 inhibition was as effective as HDACi at increasing Sox2 expression in colon cancer cell lines [87].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [87]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“K75 exists within Sox2’s nuclear export signal (NES) and is necessary for Sox2’s ability to interact with nuclear export receptor protein Crm1 [87].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [87]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sox2’s acetylation was further connected to cellular metabolism as acetyl-CoA synthetase 2 (ACSS2, a key acetyl-CoA producing enzyme) expression was inversely correlated with Sox2 expression, so much so that ACSS2 inhibition was as effective as HDACi at increasing Sox2 expression in colon cancer cell lines [87].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [87]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In colon cancer, Sox2, a transcription factor involved in stem cell maintenance [86], is degraded at higher rates following its p300-mediated acetylation at K75 (Figure 3E) [87].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [87]
The cited source says what the claim attributes to it.
In the citing paper
“Subsequently, Sox2’s acetylation-mediated change in subcellular localization results in an increase of Sox2 ubiquitination and degradation (which is countered by the deacetylase for this mark, HDAC4) (Figure 3E) [87].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Li, Y., Wang, K., Wei, Y., Yao, Q., Zhang, Q., Qu, H., & Zhu, G. (2017) · Oncology Reports · doi:10.3892/or.2017.6020 · Cited by 64 · cited 1×
“In a previous study, TGF-β 1 was reported to reduce miR29a expression, promoting tumorigenicity and metastasis of cholangiocarcinoma by upregulating HDAC4 [31,47].”
BackgroundRetractedTANDEM: matching proteins with tandem mass spectra
Craig, R., & Beavis, R. C. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth092 · Cited by 2,536
ProteoWizard: open source software for rapid proteomics tools development
Kessner, D., Chambers, M., Burke, R., Agus, D., & Mallick, P. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn323 · Cited by 2,024
MS-GF+ makes progress towards a universal database search tool for proteomics
Kim, S., & Pevzner, P. A. (2014) · Nature Communications · doi:10.1038/ncomms6277 · Cited by 1,098 · cited 1×
“Data files were searched with X!tandem [16], MyriMatch [17], and MS-GF+ [18] using SearchGUI [19] against the Homo sapiens database on UniProt and using PeptideShaker [20] against a custom database downloaded from UniProt.”
MethodDonohoe, D. R., Collins, L. B., Wali, A., Bigler, R., Sun, W., & Bultman, S. J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.033 · Cited by 993 · cited 2×
“However, in CRC, expression of ACSS2 is reduced because of the reliance of CRC cells on glycolysis as their primary energy source [40,41].”
BackgroundLee, H.-J., Suk, J.-E., Patrick, C., Bae, E.-J., Cho, J.-H., Rho, S., Hwang, D., Masliah, E., & Lee, S.-J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081125 · Cited by 877 · cited 1×
“Using the normalized intensities, genes with differential expression between SW480 cells and SW620 cells were determined by a previously reported integrated statistical method [14].”
MethodPairing SOX off: with partners in the regulation of embryonic development
Kamachi, Y., Uchikawa, M., & Kondoh, H. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01955-1 · Cited by 639
Sox proteins: regulators of cell fate specification and differentiation
Kamachi, Y., & Kondoh, H. (2013) · Development · doi:10.1242/dev.091793 · Cited by 572 · cited 1×
“Most of these modifications affect the nucleocytoplasmic shuttling of Sox2, possibly by modulating interactions with binding partners and cofactors [8].”
BackgroundTabb, D. L., Fernando, C. G., & Chambers, M. C. (2007) · Journal of Proteome Research · doi:10.1021/pr0604054 · Cited by 546 · cited 1×
“Data files were searched with X!tandem [16], MyriMatch [17], and MS-GF+ [18] using SearchGUI [19] against the Homo sapiens database on UniProt and using PeptideShaker [20] against a custom database downloaded from UniProt.”
MethodPeptideShaker enables reanalysis of MS-derived proteomics data sets
Vaudel, M., Burkhart, J. M., Zahedi, R. P., Oveland, E., Berven, F. S., Sickmann, A., Martens, L., & Barsnes, H. (2015) · Nature Biotechnology · doi:10.1038/nbt.3109 · Cited by 522 · cited 2×
“…using anti-Flag antibody-conjugated agarose beads (80 µ L of 50% slurry) from about 90 mg of extracts that had been washed with buffer [20 mM Tris-HCl (pH 7.9), 15% glycerol, 1 mM EDTA, 1 mM dithiothreitol (DTT), 0.2 mM PMSF, 0.05% Nonidet P40, and 150 mM KCl] to remove non-specific…”
MethodInfluentialRegulation of autophagy by cytosolic acetyl-coenzyme A
Mariño, G., Pietrocola, F., Eisenberg, T., Kong, Y., Malik, S. A., Andryushkova, A., Schroeder, S., Pendl, T., Harger, A., Niso-Santano, M., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.01.016 · Cited by 500
Regulation of the p300 HAT domain via a novel activation loop
Thompson, P. R., Wang, D., Wang, L., Fulco, M., Pediconi, N., Zhang, D., An, W., Ge, Q., Roeder, R. G., Wong, J., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb740 · Cited by 423 · cited 2×
“The intracellular metabolic intermediate acetyl-CoA plays a crucial role in p300 activation by providing acetyl groups both for p300 substrates and also for p300 autoacetylation, a critical event that marks p300 activation [24,25].”
BackgroundSearchGUI: An open‐source graphical user interface for simultaneous OMSSA and X!Tandem searches
Vaudel, M., Barsnes, H., Berven, F. S., Sickmann, A., & Martens, L. (2011) · PROTEOMICS · doi:10.1002/pmic.201000595 · Cited by 356 · cited 1×
“Data files were searched with X!tandem [16], MyriMatch [17], and MS-GF+ [18] using SearchGUI [19] against the Homo sapiens database on UniProt and using PeptideShaker [20] against a custom database downloaded from UniProt.”
MethodO-GlcNAc signaling: a metabolic link between diabetes and cancer?
Slawson, C., Copeland, R. J., & Hart, G. W. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.04.005 · Cited by 346 · cited 1×
“O -GlcNAcylation is a process in which GlcNAc from UDP-GlcNAc is transferred to protein serine or threonine residues, reflecting the nutritional status of cells [48].”
BackgroundSOX2 in development and cancer biology
Novak, D., Hüser, L., Elton, J. J., Umansky, V., Altevogt, P., & Utikal, J. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.007 · Cited by 328 · cited 1×
“In addition, high Sox2 expression has been associated with poor prognosis and resistance to chemotherapy and radiotherapy, potentially as a result of its influence on cancer stem cell characteristics [6].”
BackgroundPhosphorylation Dynamics during Early Differentiation of Human Embryonic Stem Cells
Van Hoof, D., Muñoz, J., Braam, S. R., Pinkse, M. W. H., Linding, R., Heck, A. J. R., Mummery, C. L., & Krijgsveld, J. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.021 · Cited by 323
Saigusa, S., Tanaka, K., Toiyama, Y., Yokoe, T., Okugawa, Y., Ioue, Y., Miki, C., & Kusunoki, M. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0617-z · Cited by 319 · cited 1×
“Several studies have demonstrated that high Sox2 mRNA expression is an independent prognostic factor for relapse-free survival in patients with CRC [22,29,30].”
BackgroundRuan, H.-B., Han, X., Li, M.-D., Singh, J. P., Qian, K., Azarhoush, S., Zhao, L., Bennett, A. M., Samuel, V. T., Wu, J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.006 · Cited by 296
Bulusu, V., Tumanov, S., Michalopoulou, E., van den Broek, N. J., MacKay, G., Nixon, C., Dhayade, S., Schug, Z. T., Vande Voorde, J., Blyth, K., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.055 · Cited by 266 · cited 2×
“Acetyl-CoA synthetase 2 (ACSS2) has been identified as an upstream factor that promotes increased activity of CBP, p300/CBP-associated factor, and other histone acetyltransferases, resulting in enhanced histone acetylation [26].”
BackgroundAlonso, M. M., Diez-Valle, R., Manterola, L., Rubio, A., Liu, D., Cortes-Santiago, N., Urquiza, L., Jauregi, P., de Munain, A. L., Sampron, N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026740 · Cited by 215
HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21
Wilson, A. J., Byun, D.-S., Nasser, S., Murray, L. B., Ayyanar, K., Arango, D., Figueroa, M., Melnick, A., Kao, G. D., Augenlicht, L. H., et al. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-02-0139 · Cited by 214 · cited 1×
“In HCT116 colon cancer cells, downregulation of HDAC4 expression was shown to inhibit growth, induce apoptosis, reduce xenograft tumor growth, and increase p21 transcription [43].”
BackgroundFang, L., Zhang, L., Wei, W., Jin, X., Wang, P., Tong, Y., Li, J., Du, J. X., & Wong, J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.06.018 · Cited by 192 · cited 1×
“Sox2 can be phosphorylated by AKT1 [50] and Aurora kinase”
BackgroundThe emerging role of class II histone deacetylases
Fischle, W., Kiermer, V., Dequiedt, F., & Verdin, E. (2001) · Biochemistry and Cell Biology · doi:10.1139/bcb-79-3-337 · Cited by 181 · cited 1×
“Among them, HDAC4, a member of the class IIa histone deacetylases, exhibits nucleocytoplasmic shuttling [42], is implicated in various cancers, and is involved in histone deacetylation leading to transcriptional repression.”
BackgroundAcetylation of Sox2 Induces its Nuclear Export in Embryonic Stem Cells
Baltus, G. A., Kowalski, M. P., Zhai, H., Tutter, A. V., Quinn, D., Wall, D., & Kadam, S. (2009) · Stem Cells · doi:10.1002/stem.168 · Cited by 169
Han, X., Fang, X., Lou, X., Hua, D., Ding, W., Foltz, G., Hood, L., Yuan, Y., & Lin, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041335 · Cited by 155
SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer
Neumann, J. H. L., Bahr, F., Horst, D. A., Kriegl, L., Engel, J., Mejías‐Luque, R., Gerhard, M., Kirchner, T., & Jung, A. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-518 · Cited by 155 · cited 2×
“Sox2 expression is rare in normal colon tissue; however, it significantly increases during CRC tumorigenesis [22].”
BackgroundJiang, M., Xu, B., Li, X., Shang, Y., Chu, Y., Wang, W., Chen, D., Wu, N., Hu, S., Zhang, S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0435-5 · Cited by 151 · cited 1×
“Another potentially important PTM, O -GlcNAcylation, has been found to be increased in CRC, facilitating the proliferative and migratory properties of tumor cells and promoting CRC metastasis [10,11].”
BackgroundYoon, D. S., Choi, Y., Jang, Y., Lee, M., Choi, W. J., Kim, S., & Lee, J. W. (2014) · Stem Cells · doi:10.1002/stem.1811 · Cited by 133 · cited 1×
“Furthermore, SIRT1-mediated deacetylation contributes to maintaining Sox2 protein in the nucleus of bone marrow mesenchymal stem cells [37].”
BackgroundSox2 is associated with cancer stem-like properties in colorectal cancer
Takeda, K., Mizushima, T., Yokoyama, Y., Hirose, H., Wu, X., Qian, Y., Ikehata, K., Miyoshi, N., Takahashi, H., Haraguchi, N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-36251-0 · Cited by 108 · cited 1×
“Several studies have demonstrated that high Sox2 mRNA expression is an independent prognostic factor for relapse-free survival in patients with CRC [22,29,30].”
BackgroundRegulation of OGT by URI in Response to Glucose Confers c-MYC-Dependent Survival Mechanisms
Burén, S., Gomes, A. L., Teijeiro, A., Fawal, M.-A., Yilmaz, M., Tummala, K. S., Pérez‐Martínez, M., Rodriguez‐Justo, M., Campos‐Olivas, R., Megías, D., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.023 · Cited by 105
Acetyl-CoA synthetase 2(ACSS2): a review with a focus on metabolism and tumor development
Ling, R., Chen, G., Tang, X., Liu, N., Zhou, Y., & Chen, D. (2022) · Discover Oncology · doi:10.1007/s12672-022-00521-1 · Cited by 97 · cited 2×
“However, in CRC, expression of ACSS2 is reduced because of the reliance of CRC cells on glycolysis as their primary energy source [40,41].”
BackgroundZeng, L.-S., Yang, X.-Z., Wen, Y., Mai, S., Wang, M.-H., Zhang, M.-Y., Zheng, X., & Wang, H. (2016) · Aging · doi:10.18632/aging.100980 · Cited by 87 · cited 1×
“Moreover, in terms of clinical outcomes, we found that HDAC4 expression and Sox2 expression were both negatively associated with survival in CRC, which matches a previous report that increased HDAC4 expression was associated with poor prognosis in esophageal cancer [44].”
ResultMyers, S. A., Peddada, S., Chatterjee, N., Friedrich, T., Tomoda, K., Krings, G., Thomas, S., Maynard, J. C., Broeker, M., Thomson, M., et al. (2016) · eLife · doi:10.7554/elife.10647 · Cited by 85 · cited 1×
“O -GlcNAcylation occurs at two positions in Sox2: S248 and T258 [12].”
BackgroundInhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism
Itkonen, H., Gorad, S. S., Duveau, D., Martin, S. E., Barkovskaya, A., Bathen, T., Moestue, S., & Mills, I. (2016) · OncoTarget · doi:10.18632/oncotarget.7039 · Cited by 83 · cited 1×
“O-GlcNAcylation and expression of O -GlcNAc transferase (OGT), the enzyme responsible for catalyzing O-GlcNAcylation, have been reported to be elevated in various cancer types, including CRC [10,32–34].”
BackgroundO-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability
Sharma, N., Gupta, V. K., Dauer, P., Kesh, K., Hadad, R., Giri, B., Chandra, A., Dudeja, V., Slawson, C. M., Banerjee, S., et al. (2019) · Theranostics · doi:10.7150/thno.32615 · Cited by 74 · cited 2×
“In pancreatic cancer, OGT is markedly overexpressed and catalyzes O -GlcNAcylation at the S246/248 residues of Sox2, stabilizing Sox2 in the nucleus and promoting self-renewal of tumor cells [13].”
BackgroundSteenackers, A., Stichelen, S. O.-V., Baldini, S. F., Dehennaut, V., Toillon, R., Bourhis, X. L., Yazidi‐Belkoura, I. E., & Lefebvre, T. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00046 · Cited by 72 · cited 2×
“Another potentially important PTM, O -GlcNAcylation, has been found to be increased in CRC, facilitating the proliferative and migratory properties of tumor cells and promoting CRC metastasis [10,11].”
BackgroundPan, F., Mao, H., Bu, F., Tong, X., Li, J., Zhang, S., Liu, X., Wang, L., Wu, L., Chen, R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13902 · Cited by 72 · cited 1×
“MiRNAs are small noncoding RNAs that play a role in post-transcriptional gene regulation and have been implicated in cancer progression [45,46].”
BackgroundChIP-seq and Functional Analysis of the SOX2 Gene in Colorectal Cancers
Fang, X., Yu, W., Li, L., Shao, J., Zhao, N., Chen, Q., Ye, Z., Lin, S., Zheng, S. S., & Lin, B. (2010) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2010.0053 · Cited by 64 · cited 2×
“A Chip-Seq analysis performed by Xuefeng Fang et al. revealed a potential link between HDAC4 and Sox2 expression, suggesting that HDAC4 may play a role in connecting histone modification and Sox2 regulation [28].”
BackgroundMethodSOX2 Expression Is Regulated by BRAF and Contributes to Poor Patient Prognosis in Colorectal Cancer
Lundberg, I. V., Löfgren‐Burström, A., Edin, S., Eklöf, V., Öberg, Å., Stenling, R., Palmqvist, R., & Wikberg, M. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101957 · Cited by 64 · cited 1×
“The underlying mechanisms driving Sox2 upregulation in the oncogenic process remain unclear [7].”
BackgroundSox2 Uses Multiple Domains to Associate with Proteins Present in Sox2-Protein Complexes
Cox, J. L., Mallanna, S. K., Luo, X., & Rizzino, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015486 · Cited by 59
Jiang, M., Qiu, Z., Zhang, S., Fan, X., Cai, X., Xu, B., Li, X., Zhou, J., Zhang, X., Chu, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11359 · Cited by 54 · cited 1×
“O-GlcNAcylation and expression of O -GlcNAc transferase (OGT), the enzyme responsible for catalyzing O-GlcNAcylation, have been reported to be elevated in various cancer types, including CRC [10,32–34].”
BackgroundSox2 Deacetylation by Sirt1 Is Involved in Mouse Somatic Reprogramming
Mu, W., Wang, Y., Xu, P., Hao, D., Liu, X., Wang, T., Chen, F., Chen, H., Lv, X., & Liu, D. (2015) · Stem Cells · doi:10.1002/stem.2012 · Cited by 53 · cited 1×
“SIRT1, a NAD-dependent deacetylase, maintains Sox2 at low levels in embryonic stem cells, and its deacetylase activity is linked to somatic cell reprogramming [36].”
BackgroundKim, B. R., Coyaud, É., Laurent, E. M. N., St‐Germain, J. R., de Laar, E. V., Tsao, M., Raught, B., & Moghal, N. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.064451 · Cited by 50 · cited 1×
“CBP/p300 was reported to promote the transcriptional activation of Sox2 by regulating its acetylation in lung cancer [23].”
BackgroundBae, J. M., Kim, J. H., Oh, H. J., Park, H. E., Lee, T. H., Cho, N., & Kang, G. H. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.172 · Cited by 47 · cited 1×
“In gastric cancer and CRC, unlike other types of cancer, lower expression of ACSS2 is associated with tumor progression and metastasis [38,39].”
BackgroundLoss of ACSS2 expression predicts poor prognosis in patients with gastric cancer
Hur, H., Kim, Y., Ham, I., & Lee, D. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.24043 · Cited by 41 · cited 1×
“In gastric cancer and CRC, unlike other types of cancer, lower expression of ACSS2 is associated with tumor progression and metastasis [38,39].”
BackgroundQi, D., Wang, Q., Yu, M., Lan, R., Li, S., & Lu, F. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1192729 · Cited by 28
Wang, H., Li, C., Jian, Z., Ou, Y., & Ou, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136703 · Cited by 26
MiR-103a-3p Contributes to the Progression of Colorectal Cancer by Regulating GREM2 Expression
Zhang, Z., & Zhu, X. (2022) · Yonsei Medical Journal · doi:10.3349/ymj.2022.63.6.520 · Cited by 24 · cited 1×
“MiRNAs are small noncoding RNAs that play a role in post-transcriptional gene regulation and have been implicated in cancer progression [45,46].”
BackgroundKim, S., Lee, J., Park, E. J., Lee, H. S., Baik, S. H., Jeon, T. J., Lee, K. Y., Ryu, Y. H., & Kang, J. (2023) · Yonsei Medical Journal · doi:10.3349/ymj.2022.0548 · Cited by 23
Current and future targets and therapies in metastatic colorectal cancer.
Džunić, M., Petković, I., Cvetanović, A., Vrbić, S., & Pejcic, I. (2019) · PubMed · Cited by 17
Poojan, S., Bae, S.-H., Min, J.-W., Lee, E. Y., Song, Y., Kim, H. Y., Sim, H. W., Kang, E., Kim, Y.-H., Lee, H., et al. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0464-3 · Cited by 15
Metastatic Colorectal Cancer: Prognostic and Predictive Factors
Nappi, A. G., Nasti, G., Romano, C., Berretta, M., & Ottaiano, A. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190620110732 · Cited by 9
Research works printed but not linked: 1
- Novak, D., Hüser, L., Elton, J.J., Umansky, V., Altevogt, P., and Utikal, J. (2020). Seminars in Cancer Biology, Academic Press.
Cited by
Acetylation: a new target for protein degradation in cancer
Crawford, C. E. W., & Burslem, G. M. (2025) · Trends in Cancer · doi:10.1016/j.trecan.2025.01.013 · Cited by 20
Sadia, K., Castagna, A., Udali, S., Ambrosani, F., Pattini, P., Beri, R., Argentino, G., Masutti, M., Moruzzi, S., & Friso, S. (2025) · Cells · doi:10.3390/cells14171337 · Cited by 22
“The interplay between histone acetylation and deacetylation patterns play a key role in the regulation of the transcriptional machinery in different carcinoma including liver cancer [18,19], colorectal cancer [20] and pancreatic cancer [21].”
Clinical Correlation of Transcription Factor SOX3 in Cancer: Unveiling Its Role in Tumorigenesis
Puerto, H. L. D., Miranda, A. P. G. S., Qutob, D., Ferreira, E. F., Silva, F. H. S., Lima, B. M., de Carvalho, B. A., Roque-Souza, B., Gutseit, E., Castro, D. C., et al. (2024) · Genes · doi:10.3390/genes15060777 · Cited by 9
Ghavidel, P., Abdelmalki, Y., & Sincennes, M. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl46704 · Cited by 2
Outissint, I., Pan, H., Lu, P., Tang, M., & Gong, X. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156485
Metadata
- Authors
- Seo, Y., Kim, D. K., Park, J., Park, S. J., Park, J. J., Cheon, J. H., & Kim, T. I.
- Affiliations
- Yonsei University (KR)
- Corresponding author
- Kim, Tae Il
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2024-03-03
- Volume
- 16
- Issue
- 5
- Pages
- 1035
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC10931190
- OpenAlex
- W4392376423
- Cited by
- 5
- References
- 53
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1
- FWCI
- 0.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Research Foundation of Korea (NRF) (2021R1A2C2011641)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- SOX2, colorectal cancer, post-translational modification, acetylation, O-GlcNAcylation, nuclear export signal, nucleocytoplasmic shuttling, proteasomal degradation, protein stability, HDAC4, P300, CBP/p300, miR-29a, pluripotency transcription factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.